Overview
Liquid biopsy leader using AI for cancer detection and monitoring.
Details
Guardant360 (advanced cancer), Guardant Reveal (MRD), and Shield (CRC screening) combine ctDNA sequencing with ML. Public on Nasdaq (GH).
Liquid biopsy leader with AI for cancer detection and monitoring. Guardant360, Guardant Reveal (MRD), and Shield (CRC screening) combine ctDNA with ML.
Liquid biopsy leader using AI for cancer detection and monitoring.
Guardant360 (advanced cancer), Guardant Reveal (MRD), and Shield (CRC screening) combine ctDNA sequencing with ML. Public on Nasdaq (GH).
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →